Profund Advisors LLC Astrazeneca PLC Transaction History

Profund Advisors LLC

  • $2.67 Billion
  • Q4 2024

A detailed history of Profund Advisors LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Profund Advisors LLC holds 49,102 shares of AZN stock, worth $3.62 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
49,102
Previous 45,216 8.59%
Holding current value
$3.62 Million
Previous $3.52 Million 8.69%
% of portfolio
0.12%
Previous 0.14%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
BUY
$63.2 - $79.58 $245,595 - $309,247
3,886 Added 8.59%
49,102 $3.22 Million
Q3 2024

Nov 13, 2024
SELL
$76.67 - $87.62 $305,759 - $349,428
-3,988 Reduced 8.11%
45,216 $3.52 Million
Q2 2024

Aug 13, 2024
SELL
$66.81 - $80.83 $24,920 - $30,149
-373 Reduced 0.75%
49,204 $3.84 Million
Q1 2024

May 08, 2024
SELL
$61.03 - $69.57 $211,041 - $240,573
-3,458 Reduced 6.52%
49,577 $3.36 Million
Q4 2023

Feb 14, 2024
BUY
$61.89 - $69.28 $440,037 - $492,580
7,110 Added 15.48%
53,035 $3.57 Million
Q3 2023

Nov 13, 2023
BUY
$64.85 - $71.7 $653,688 - $722,736
10,080 Added 28.12%
45,925 $3.11 Million
Q2 2023

Aug 10, 2023
SELL
$69.91 - $75.81 $138,771 - $150,482
-1,985 Reduced 5.25%
35,845 $2.57 Million
Q1 2023

May 11, 2023
SELL
$63.15 - $71.6 $39,216 - $44,463
-621 Reduced 1.62%
37,830 $2.63 Million
Q4 2022

Feb 02, 2023
BUY
$54.21 - $70.44 $91,181 - $118,480
1,682 Added 4.57%
38,451 $2.61 Million
Q3 2022

Nov 04, 2022
SELL
$53.02 - $135.75 $123,907 - $317,247
-2,337 Reduced 5.98%
36,769 $2.02 Million
Q2 2022

Aug 01, 2022
SELL
$59.26 - $71.14 $442,731 - $531,486
-7,471 Reduced 16.04%
39,106 $2.58 Million
Q1 2022

May 10, 2022
BUY
$55.72 - $67.12 $1.72 Million - $2.08 Million
30,931 Added 197.69%
46,577 $3.09 Million
Q4 2021

Feb 08, 2022
BUY
$54.02 - $63.83 $1,944 - $2,297
36 Added 0.23%
15,646 $911,000
Q3 2021

Nov 12, 2021
BUY
$55.56 - $60.79 $36,169 - $39,574
651 Added 4.35%
15,610 $938,000
Q2 2021

Aug 12, 2021
BUY
$48.42 - $60.18 $19,222 - $23,891
397 Added 2.73%
14,959 $896,000
Q1 2021

May 14, 2021
BUY
$47.16 - $54.44 $24,240 - $27,982
514 Added 3.66%
14,562 $724,000
Q4 2020

Feb 09, 2021
BUY
$48.52 - $58.02 $65,744 - $78,617
1,355 Added 10.68%
14,048 $702,000
Q3 2020

Nov 13, 2020
SELL
$53.07 - $61.1 $191,105 - $220,021
-3,601 Reduced 22.1%
12,693 $696,000
Q2 2020

Aug 03, 2020
BUY
$43.1 - $55.31 $127,403 - $163,496
2,956 Added 22.16%
16,294 $862,000
Q1 2020

May 15, 2020
SELL
$37.79 - $51.33 $154,372 - $209,683
-4,085 Reduced 23.45%
13,338 $596,000
Q4 2019

Feb 18, 2020
SELL
$42.46 - $50.46 $188,692 - $224,244
-4,444 Reduced 20.32%
17,423 $869,000
Q3 2019

Nov 12, 2019
SELL
$40.12 - $45.47 $117,190 - $132,817
-2,921 Reduced 11.78%
21,867 $975,000
Q2 2019

Aug 13, 2019
BUY
$37.28 - $41.68 $12,824 - $14,337
344 Added 1.41%
24,788 $1.02 Million
Q1 2019

May 15, 2019
BUY
$35.49 - $43.02 $142,208 - $172,381
4,007 Added 19.61%
24,444 $988,000
Q4 2018

Feb 14, 2019
SELL
$36.86 - $41.49 $300,888 - $338,682
-8,163 Reduced 28.54%
20,437 $776,000
Q3 2018

Nov 13, 2018
SELL
$34.76 - $39.72 $17,380 - $19,860
-500 Reduced 1.72%
28,600 $1.13 Million
Q2 2018

Aug 13, 2018
SELL
$34.55 - $37.05 $55,279 - $59,279
-1,600 Reduced 5.21%
29,100 $1.02 Million
Q1 2018

May 14, 2018
SELL
$32.97 - $36.63 $820,953 - $912,087
-24,900 Reduced 44.78%
30,700 $1.07 Million
Q4 2017

Feb 14, 2018
SELL
$32.09 - $34.78 $208,199 - $225,652
-6,488 Reduced 10.45%
55,600 $1.93 Million
Q3 2017

Nov 13, 2017
BUY
$28.96 - $34.0 $484,906 - $569,296
16,744 Added 36.93%
62,088 $2.1 Million
Q2 2017

Aug 11, 2017
BUY
N/A
45,344
45,344 $1.55 Million

Others Institutions Holding AZN

# of Institutions
1,355
Shares Held
512M
Call Options Held
6.08M
Put Options Held
4.44M
View Full List

About ASTRAZENECA PLC

AZN Quotes by TradingView
  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $229B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Profund Advisors LLC Portfolio

Follow Profund Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Profund Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Profund Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email